🏛️ Verified NIH Record • Updated 2025-10-20
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata (NCT03898479)
A Multicenter, Open-Label, Extension Study to Assess the Long-Term Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
🔵 Active, Not Recruiting Phase2 / Phase3 💊 Investigational Drug / Biologic Sponsor: Sun Pharmaceutical Industries, Inc.
🩺 Plain-English Summary (8th-Grade Level)
The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in adult patients with chronic, moderate to severe alopecia areata.
Who can join: Review the eligibility criteria below.
Location: Total Skin and Beauty Dermatology Center — Birmingham, Alabama
Age range: 18 Years to 65 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (91 Sites)
Showing the first 25 of 91 sites.
- Total Skin and Beauty Dermatology Center — Birmingham, Alabama
- Alliance Dermatology & MOHS Center — Phoenix, Arizona
- Center for Dermatology and Plastic Surgery/CCT Research — Scottsdale, Arizona
- Johnson Dermatology — Fort Smith, Arkansas
- Northwest Arkansas Clinical Trials Center, PLLC — Rogers, Arkansas
- Kern Research Inc. — Bakersfield, California
- Hope Clinical Research — Canoga Park, California
- California Dermatology & Clinical Research Institute — Encinitas, California
- University of California, Irvine — Irvine, California
- Dermatology Research Associates — Los Angeles, California
- Quest Dermatology Research — Northridge, California
- Kaiser Permanente Northern California - Oakland — Oakland, California
- Palmtree Clinical Research, Inc. — Palm Springs, California
- Stanford University School of Medicine - Medical Dermatology Clinic — Redwood City, California
- Kaiser Permanente South Sacramento — Sacramento, California
- Kaiser Permanente Clinical Trials Unit — San Francisco, California
- Colorado Center for Dermatology, PLLC d/b/a CODerm Research — Centennial, Colorado
- Colorado Medical Research Center — Denver, Colorado
- Yale University Church Street Research Unit — New Haven, Connecticut
- Skin Care Research, LLC — Boca Raton, Florida
- Skin Care Research, LLC — Hollywood, Florida
- University of Miami Hospital — Miami, Florida
- Floridian Research Institute, LLC — Miami, Florida
- Lenus Research & Medical Group, LLC — Sweetwater, Florida
- Clinical Research Trials of Florida, Inc. — Tampa, Florida
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Alopecia Areata
- A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo — Northridge, California
- A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA) — Northridge, California
- Alopecia Areata Registry — San Francisco, California
- Intralesional Cyclosporine for Alopecia Areata — Sacramento, California
- A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA) — Scottsdale, Arizona
Explore by condition: All Alopecia Areata clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.